|
Recent Developments |
|
15-MAY-18
Jubilant Life Sciences, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the company,
30-JAN-18
Jubilant Life Sciences, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma, a material wholly owned subsidiary of the company, through one of its wholly owned subsidiaries, has received Abbreviated ... More.. |
| Business Profile |
Future Plans |
|
| CEO Talk | | Jubilant Organosys Ltd is growing steadily, following improvement in its manufacturing performance and emphasis on speciality chemicals and exports. With a new corporate identity, the company is looking forward to a bright future. Shyam Bhartiya |
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2016(12) | 31-Mar-2015 (12) | 31-Mar-2014 (12) | | Net sales | 26075.20 | 31406.20 | 36275.10 | | Other Income | 617.40 | 1064.20 | 298.80 | | Total Income | 26692.60 | 32470.40 | 36573.90 | | Cost of goods sold | 23152.80 | 29001.30 | 30910.90 | | OPBDIT | 3539.80 | 3469.10 | 5663.00 | | PAT | 790.70 | 2051.10 | 8.20 | | Gross Block | - | - | - | | Equity capital | 159.30 | 159.30 | 159.30 | | EPS (Rs.) | - | 12.88 | 0.05 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 9.01 - 17.24 | 1302.00 - 3736.00 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 13.3 | 10.7 | 15.5 | | Net margin (% of OI) | 3.0 | 6.3 | 0.0 |
|
|
Detailed Financials
|
|
|
|
|
